Previous BHITS Studies: Institutional Review Board (IRB) Approved Clinical Research Studies

  • Retrospective Chart Review Study of Human Umbilical Cord Blood Mononuclear Cell Therapy in Previously Treated Subjects with Brain Trauma (IRCM-2019-231, December 10, 2019).
  • Evaluation of The Long-Term Safety of Human Umbilical Cord Blood Derived Mononuclear Cell Therapy in Previously Treated Subjects with Chronic Inflammation (IRCM-2019-232, December 10, 2019).
  • Evaluation of the Safety and Efficacy of HPC, Cord Blood in Subjects with Acute Ischemic Stroke (IRCM-2018-188, July 13, 2018)
  • Retrospective Chart Review Study of Human Cord Blood Stem Cells in the Therapy of Symptoms Related to Chronic Inflammation (IRCM-2017-136, January 18, 2017)
  • Retrospective Chart Review Study of Human Adipose Tissue Derived Mesenchymal Stem Cell Therapy in Subjects with Musculoskeletal Conditions (IRCM-2017-137, January 18, 2017)
  • Retrospective Chart Review Study of Human Umbilical Cord Blood Derived Mesenchymal Stem Cell Therapy in Subjects with Stroke (IRCM-2017-135, January 18, 2017)
  • Umbilical Cord Blood Mononuclear Cell Therapy for Spinal Cord Injury – A Retrospective Cohort Study (Office of Research and Sponsored Programs. SC# 5488, “Spinal Cord Injury Stem Cell Therapy”, April 2, 2014)
  • Evaluation of Immune response to Intravenously Administered Human Cord Blood Stem Cells in the treatment of Symptoms related to Chronic Inflammation (IRCM 2014-040, December 17, 2014)

Used Stem Cell Sources, Treatment Modalities and Outcome Measures

Stem Cell Sources:

  • Allogeneic Human Umbilical cord blood
  • Allogeneic Wharton’s jelly
  • Autologous Bone Marrow
  • Autologous Adipose Tissue

Treatment Modalities:

  • Intravenous Infusion
  • Intrathecal Injection
  • Intra-Articular Injection

Treatment modalities, specific for the medical condition, descried in our Institutional Review Board-approved research protocols.

Outcome Measures:

  • Safety evaluation – conduct of adverse events form, medical history, physical exam, specific blood tests at intervals described in the research protocol.
  • Assessment of efficacy – conduct of specific blood tests, exams and self-assessment questionnaires at intervals described in the research protocol.